Peter M Izmirly1, Jill P Buyon1, Isabella Wan1, H Michael Belmont1, Sara Sahl2, Jane E Salmon3, Anca Askanase4, Joan M Bathon4, Laura Geraldino-Pardilla4, Yousaf Ali5, Ellen M Ginzler6, Chaim Putterman7, Caroline Gordon8, Charles G Helmick9, Hilary Parton10. 1. New York University School of Medicine, New York, New York. 2. Harbor-University of California Medical Center, Los Angeles. 3. Hospital for Special Surgery, Weill Cornell Medical College, New York, New York. 4. Columbia University College of Physicians & Surgeons, New York, New York. 5. Icahn School of Medicine at Mount Sinai, New York, New York. 6. State University of New York Downstate College of Medicine, Brooklyn. 7. Albert Einstein College of Medicine, Bronx, New York. 8. University of Birmingham, Birmingham, United Kingdom. 9. Centers for Disease Control and Prevention, Atlanta, Georgia. 10. New York City Department of Health and Mental Hygiene, Long Island City, New York.
Abstract
OBJECTIVE: Extant epidemiologic data of primary Sjögren's syndrome (SS) remains limited, particularly for racial/ethnic populations in the US. The Manhattan Lupus Surveillance Program (MLSP) is a population-based retrospective registry of cases of systemic lupus erythematosus and related diseases, including primary SS in Manhattan, New York. The MLSP was used to provide estimates of the incidence and prevalence of primary SS across major racial/ethnic populations. METHODS: MLSP cases were identified from hospitals, rheumatologists, and population databases. Three case definitions were used for primary SS, including physician diagnosis, rheumatologist diagnosis, and modified primary SS criteria. Rates among Manhattan residents were age-adjusted, and capture-recapture analyses were conducted to assess underascertainment of cases. RESULTS: By physician diagnosis, age-adjusted overall incidence and prevalence rates of primary SS among adult Manhattan residents were 3.5 and 13.1 per 100,000 person-years, respectively. Capture-recapture adjustment increased incidence and prevalence rates (4.1 and 14.2 per 100,000 person-years, respectively). Based on physician diagnosis, incidence and prevalence rates were approximately 6 times higher among women than men (P < 0.001). Incidence of primary SS was statistically higher among non-Latina Asian women (10.5) and non-Latina white women (6.2) compared with Latina women (3.2). Incidence was also higher among non-Latina Asian women compared with non-Latina black women (3.3). Prevalence of primary SS did not differ by race/ethnicity. Similar trends were observed when more restrictive case definitions were applied. CONCLUSION: Data from the MLSP revealed disparities among Manhattan residents in primary SS incidence and prevalence by sex and differences in primary SS incidence by race/ethnicity among women. These data also provided epidemiologic estimates for the major racial/ethnic populations in the US.
OBJECTIVE: Extant epidemiologic data of primary Sjögren's syndrome (SS) remains limited, particularly for racial/ethnic populations in the US. The Manhattan Lupus Surveillance Program (MLSP) is a population-based retrospective registry of cases of systemic lupus erythematosus and related diseases, including primary SS in Manhattan, New York. The MLSP was used to provide estimates of the incidence and prevalence of primary SS across major racial/ethnic populations. METHODS: MLSP cases were identified from hospitals, rheumatologists, and population databases. Three case definitions were used for primary SS, including physician diagnosis, rheumatologist diagnosis, and modified primary SS criteria. Rates among Manhattan residents were age-adjusted, and capture-recapture analyses were conducted to assess underascertainment of cases. RESULTS: By physician diagnosis, age-adjusted overall incidence and prevalence rates of primary SS among adult Manhattan residents were 3.5 and 13.1 per 100,000 person-years, respectively. Capture-recapture adjustment increased incidence and prevalence rates (4.1 and 14.2 per 100,000 person-years, respectively). Based on physician diagnosis, incidence and prevalence rates were approximately 6 times higher among women than men (P < 0.001). Incidence of primary SS was statistically higher among non-Latina Asian women (10.5) and non-Latina white women (6.2) compared with Latina women (3.2). Incidence was also higher among non-Latina Asian women compared with non-Latina black women (3.3). Prevalence of primary SS did not differ by race/ethnicity. Similar trends were observed when more restrictive case definitions were applied. CONCLUSION: Data from the MLSP revealed disparities among Manhattan residents in primary SS incidence and prevalence by sex and differences in primary SS incidence by race/ethnicity among women. These data also provided epidemiologic estimates for the major racial/ethnic populations in the US.
Authors: C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman Journal: Ann Rheum Dis Date: 2002-06 Impact factor: 19.103
Authors: S C Shiboski; C H Shiboski; L A Criswell; A N Baer; S Challacombe; H Lanfranchi; M Schiødt; H Umehara; F Vivino; Y Zhao; Y Dong; D Greenspan; A M Heidenreich; P Helin; B Kirkham; K Kitagawa; G Larkin; M Li; T Lietman; J Lindegaard; N McNamara; K Sack; P Shirlaw; S Sugai; C Vollenweider; J Whitcher; A Wu; S Zhang; W Zhang; J S Greenspan; T E Daniels Journal: Arthritis Care Res (Hoboken) Date: 2012-04 Impact factor: 4.794
Authors: Emily C Somers; Wendy Marder; Patricia Cagnoli; Emily E Lewis; Peter DeGuire; Caroline Gordon; Charles G Helmick; Lu Wang; Jeffrey J Wing; J Patricia Dhar; James Leisen; Diane Shaltis; W Joseph McCune Journal: Arthritis Rheumatol Date: 2014-02 Impact factor: 10.995
Authors: S Sam Lim; A Rana Bayakly; Charles G Helmick; Caroline Gordon; Kirk A Easley; Cristina Drenkard Journal: Arthritis Rheumatol Date: 2014-02 Impact factor: 10.995
Authors: Maria Dall'Era; Miriam G Cisternas; Kurt Snipes; Lisa J Herrinton; Caroline Gordon; Charles G Helmick Journal: Arthritis Rheumatol Date: 2017-09-10 Impact factor: 10.995
Authors: R M Clancy; M C Marion; H C Ainsworth; M J Blaser; M Chang; T D Howard; P M Izmirly; C Lacher; M Masson; K Robins; J P Buyon; C D Langefeld Journal: J Autoimmun Date: 2019-10-31 Impact factor: 7.094
Authors: Sara A Miller-Archie; Peter M Izmirly; Jessica R Berman; Jennifer Brite; Deborah J Walker; Renato C Dasilva; Lysa J Petrsoric; James E Cone Journal: Arthritis Rheumatol Date: 2020-04-01 Impact factor: 10.995
Authors: Tabea Seeliger; Nils K Prenzler; Stefan Gingele; Benjamin Seeliger; Sonja Körner; Thea Thiele; Lena Bönig; Kurt-Wolfram Sühs; Torsten Witte; Martin Stangel; Thomas Skripuletz Journal: Front Immunol Date: 2019-07-11 Impact factor: 7.561
Authors: Peter Izmirly; Jill Buyon; H Michael Belmont; Sara Sahl; Isabella Wan; Jane Salmon; Anca Askanase; Joan M Bathon; Laura Geraldino-Pardilla; Yousaf Ali; Ellen Ginzler; Chaim Putterman; Caroline Gordon; Charles Helmick; Hilary Parton Journal: Lupus Sci Med Date: 2019-10-30